Cancer Family
Glandular Cell Neoplasm
CI-CAN-00000188Explore in graph →
Non-malignant2,823 active trials43 approved drugs426 evidence items
- NCIt
- C7132
Loading cancer entity…
Cancer Family
CI-CAN-00000188Explore in graph →
Clinical trials
10,205 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00043433 | Study of T900607-Sodium in Chemotherapy Naive Patients With Hepatocellular Carcinoma. | unknown | Phase 2 | 35 | TularikINDUSTRY | 2 | Jun 24, 2005 | clinicaltrials |
| NCT00051675 | Phase I Study of a Monoclonal Antibody for Treatment of Advanced Adenocarcinomas | completed | Phase 1 | 30 | XOMA (US) LLCINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00054951 |
| Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads |
| unknown |
| Phase 1 / Phase 2 |
| 30 |
| FeRxINDUSTRY |
| 1 |
| Jun 24, 2005 |
| clinicaltrials |
| NCT00057382 | T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients | terminated | Phase 2 / Phase 3 | 750 | TularikINDUSTRY | 11 | Jun 24, 2005 | clinicaltrials |
| NCT00057395 | A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies | unknown | Phase 1 / Phase 2 | 40 | Aronex PharmaceuticalsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
Data updated 23 days agoSource updated Jun 24, 2005source: clinicaltrials